GLP‑1–pathway agonists such as semaglutide and newer multi‑agonists have transformed care for obesity and diabetes, yet ...
GLP-1–pathway agonists such as semaglutide and newer multi-agonists have transformed care for obesity and diabetes, yet developers still wrestle with durability, tissue targeting, and signal "bias." ...
15hon MSN
Eating 2 to 3 kiwis a day can relieve chronic constipation, according to new dietary guidelines
Do you often experience difficulty defecating? If the answer is yes, newly released recommendations may help relieve your ...
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapiesTopline safety, ...
Light responsive nanomotors dissolve blood clots and repair vessel tissue by combining catalytic activity, targeted motion, and gentle heating for coordinated thrombolysis and endothelial regeneration ...
The word “flavonoids” pops up in many discussions about food and diets but just what are they? Flavonoids (also known as ...
PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC) to address significant unmet medical ...
Discover five promising Prader-Willi syndrome therapies climbing the clinical ladder and nearing FDA approval in the coming ...
Pratteln, Switzerland, October 9, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Biomedica for the distribution of AGAMREE® (vamorolone) in Russia, ...
Scientists built a complete wheat gene map showing how different genes control plant growth and stress response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback